Literature DB >> 16511058

Refolding, crystallization and preliminary X-ray structural studies of the West Nile virus envelope (E) protein domain III.

Fang Yuan1, Zhiyong Lou, Xiaofeng Li, Yu Wai Chen, John I Bell, Zihe Rao, George F Gao.   

Abstract

Domain III of the West Nile virus envelope protein, the putative receptor-binding domain, is a major virion-surface determinant for virulence. This protein was reported to be intrinsically unstable and has defied previous crystallization attempts. It has now been purified from inclusion bodies by protein refolding and was crystallized using the hanging-drop vapour-diffusion method at 291 K. The crystals belong to space group P222(1), with unit-cell parameters a = 52.6, b = 59.7, c = 95.0 A. A complete data set was collected to 2.8 A at 100 K with Cu Kalpha X-rays from a rotating-anode generator.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511058      PMCID: PMC1952430          DOI: 10.1107/S1744309105008195

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  12 in total

1.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus.

Authors:  David E Volk; David W C Beasley; Deborah A Kallick; Michael R Holbrook; Alan D T Barrett; David G Gorenstein
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

3.  Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

Authors:  J J H Chu; R Rajamanonmani; J Li; R Bhuvanakantham; J Lescar; M-L Ng
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

4.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

6.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

7.  Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site.

Authors:  C W Mandl; S L Allison; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses.

Authors:  Shaoning Yu; Alice Wuu; Reneeta Basu; Michael R Holbrook; Alan D T Barrett; J Ching Lee
Journal:  Biochemistry       Date:  2004-07-20       Impact factor: 3.162

9.  Identification of naturally occurring monoclonal antibody escape variants of louping ill virus.

Authors:  G F Gao; M H Hussain; H W Reid; E A Gould
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

Review 10.  Structures and mechanisms in flavivirus fusion.

Authors:  F X Heinz; S L Allison
Journal:  Adv Virus Res       Date:  2000       Impact factor: 9.937

View more
  2 in total

1.  Characterization and application of monoclonal antibodies specific to West Nile virus envelope protein.

Authors:  June Liu; Bohua Liu; Zhen Cao; Shingo Inoue; Kouichi Morita; Kegong Tian; Qingyu Zhu; George F Gao
Journal:  J Virol Methods       Date:  2008-11-05       Impact factor: 2.014

2.  An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.

Authors:  Dhiraj Acharya; Fengwei Bai
Journal:  Methods Mol Biol       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.